Stephens Has Lowered Expectations for Simulations Plus (NASDAQ:SLP) Stock Price

Simulations Plus (NASDAQ:SLP - Get Free Report) had its target price dropped by Stephens from $28.00 to $20.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an "overweight" rating on the technology company's stock. Stephens' price target indicates a potential upside of 50.97% from the stock's previous close.

A number of other brokerages have also recently weighed in on SLP. BTIG Research dropped their price target on shares of Simulations Plus from $41.00 to $25.00 and set a "buy" rating for the company in a research report on Monday, July 7th. Wall Street Zen upgraded shares of Simulations Plus from a "sell" rating to a "hold" rating in a report on Monday, April 28th. KeyCorp downgraded shares of Simulations Plus from an "overweight" rating to a "sector weight" rating in a research report on Tuesday. William Blair restated an "outperform" rating on shares of Simulations Plus in a research report on Tuesday, June 3rd. Finally, JMP Securities restated a "market perform" rating on shares of Simulations Plus in a research report on Wednesday, June 18th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $26.50.

Simulations Plus Stock Performance

Simulations Plus stock traded up $0.28 during trading hours on Tuesday, hitting $13.25. The company had a trading volume of 884,686 shares, compared to its average volume of 296,111. The company has a 50-day moving average price of $24.12 and a two-hundred day moving average price of $28.18. Simulations Plus has a 1 year low of $12.89 and a 1 year high of $44.33. The firm has a market cap of $266.42 million, a P/E ratio of -4.15 and a beta of 0.83.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its quarterly earnings data on Monday, July 14th. The technology company reported $0.45 earnings per share for the quarter, topping analysts' consensus estimates of $0.26 by $0.19. Simulations Plus had a negative net margin of 78.63% and a positive return on equity of 10.65%. The firm had revenue of $20.36 million for the quarter, compared to analyst estimates of $22.83 million. During the same quarter in the prior year, the business earned $0.27 earnings per share. The business's quarterly revenue was up 9.8% compared to the same quarter last year. As a group, equities research analysts anticipate that Simulations Plus will post 1.09 EPS for the current year.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the transaction, the director owned 3,344,157 shares in the company, valued at approximately $112,062,701.07. This trade represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 19.40% of the stock is owned by corporate insiders.

Institutional Trading of Simulations Plus

Several institutional investors have recently added to or reduced their stakes in SLP. Rice Hall James & Associates LLC increased its stake in shares of Simulations Plus by 15.9% in the first quarter. Rice Hall James & Associates LLC now owns 106,082 shares of the technology company's stock valued at $2,601,000 after buying an additional 14,582 shares during the period. GAMMA Investing LLC boosted its holdings in Simulations Plus by 20,727.1% in the first quarter. GAMMA Investing LLC now owns 17,703 shares of the technology company's stock worth $434,000 after acquiring an additional 17,618 shares in the last quarter. North Star Investment Management Corp. bought a new position in Simulations Plus in the first quarter worth approximately $1,300,000. D. E. Shaw & Co. Inc. lifted its holdings in shares of Simulations Plus by 100.0% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 53,332 shares of the technology company's stock valued at $1,487,000 after purchasing an additional 26,661 shares in the last quarter. Finally, Sei Investments Co. bought a new position in shares of Simulations Plus in the fourth quarter valued at approximately $330,000. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.